VALBIOTIS (EPA:ALVAL)

BRIEF

published on 01/26/2026 at 17:45, 8 months 27 days ago

Valbiotis Offers 20% Discount to Shareholders

Valbiotis Dietary Supplements Shareholder Discount ValbiotisPRO ValbiotisPLUS
PRESS RELEASE

published on 01/26/2026 at 17:40, 8 months 27 days ago

VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges
Valbiotis launches a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges exclusively for its shareholders, strengthening the link with them and rewarding their commitment

Shareholders Valbiotis Discount Health Supplements
BRIEF

published on 01/19/2026 at 17:50, 9 months 3 days ago

Half-year review of Valbiotis' liquidity contract

Liquidity Contract AMF PORTZAMPARC Valbiotis Securities And Euros
BRIEF

published on 01/19/2026 at 17:50, 9 months 3 days ago

VALBIOTIS SA: Information on voting rights and shares as of December 31, 2025

Voting Rights Actions Euronext Growth Valbiotis Participation Thresholds
BRIEF

published on 01/19/2026 at 17:50, 9 months 3 days ago

Valbiotis Liquidity Contract Half-Yearly Report

Securities Liquidity Contract Transactions PORTZAMPARC Valbiotis
BRIEF

published on 01/12/2026 at 17:45, 9 months 10 days ago

Valbiotis publishes scientific advances on TOTUM-448

Valbiotis Metabolic Diseases Bioavailability TOTUM-448 Scientific Reports
BRIEF

published on 01/12/2026 at 17:45, 9 months 10 days ago

Valbiotis Publishes New Study on TOTUM-448 for MASLD

Valbiotis Bioavailability MASLD TOTUM-448 Scientific Publication
PRESS RELEASE

published on 01/12/2026 at 17:40, 9 months 10 days ago

VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)
Valbiotis announces publication in Scientific Reports on TOTUM-448, active substance for metabolic liver disease, presenting results from human study

Valbiotis Bioavailability TOTUM-448 Scientific Publication Metabolic Liver Disease
BRIEF

published on 01/08/2026 at 17:45, 9 months 14 days ago

Valbiotis signs an exclusive distribution agreement in the Middle East

Middle East Partnership Valbiotis Dietary Supplements Distribution
BRIEF

published on 01/08/2026 at 17:45, 9 months 14 days ago

Valbiotis Enters Middle East Market with Exclusive Distribution Deal

Distribution Agreement Middle East Valbiotis International Expansion Cardiometabolic Prevention

Published on 10/23/2026 at 13:23, 2 hours 37 minutes ago

Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 3 hours ago

First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 02:20, 13 hours 40 minutes ago

Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 16 hours 30 minutes ago

Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 17 hours 30 minutes ago

Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update

View all ACCESSWIRE

Published on 10/23/2026 at 15:48, 11 minutes ago

EU RIS CSDS Individual - Appointment of Custodian
Published on 10/23/2026 at 15:47, 13 minutes ago

EU RIS CSDS Index - Appointment of Custodian
Published on 10/23/2026 at 15:40, 19 minutes ago

Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 15:25, 34 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/23/2026 at 15:24, 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

View all EQS

Published on 10/23/2026 at 07:00, 9 hours ago

Safran reports third quarter 2026 revenue
Published on 10/22/2026 at 18:00, 22 hours ago

THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 22 hours ago

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 22 hours ago

H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 22 hours 12 minutes ago

Aéroports de Paris SA - 2026 9-month revenue

View all LES ECHOS COMFI WIRE

News